DG Capital Management’s United Therapeutics UTHR Stock Holding History

DG Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$302K	Hold	558	–	–	0.06%	26
2026 Q1	$331K	Hold	558	–	–	0.1%	25
2025 Q4	$272K	Hold	558	–	–	0.12%	20
2025 Q3	$234K	Buy	+558	New	+$188K	0.08%	19
2023 Q4	–	Sell	-52,913	Closed	-$12M	–	28
2023 Q3	$12M	Buy	52,913 +36,333	+219%	+$8.37M	6.54%	7
2023 Q2	$3.66M	Sell	16,580 -36,700	-69%	-$8.13M	1.63%	21
2023 Q1	$11.9M	Buy	+53,280	New	+$13.1M	6.71%	6
2022 Q2	–	Sell	-108,955	Closed	-$19.5M	–	80
2022 Q1	$19.5M	Sell	108,955 -28,299	-21%	-$5.39M	3.91%	10
2021 Q4	$29.7M	Buy	137,254 +7,223	+6%	+$1.42M	4.87%	3
2021 Q3	$24M	Sell	130,031 -10,268	-7%	-$2.02M	4.87%	3
2021 Q2	$25.2M	Buy	140,299 +828	+0.6%	+$158K	5.43%	2
2021 Q1	$23.3M	Buy	139,471 +46,055	+49%	+$7.68M	5.57%	1
2020 Q4	$14.2M	Buy	+93,416	New	+$12.3M	6%	3

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

DG Capital Management's UTHR Position: Q2 2026 in Review

DG Capital Management held its United Therapeutics (UTHR) position steady in Q2 2026 at 558 shares worth $302K. The position accounts for 0.06% of the portfolio, ranked #26.

DG Capital Management first reported a position in UTHR in Q4 2020 and has held it in 13 quarters since. The position peaked at $29.7M in Q4 2021. 881 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

DG Capital Management held 558 shares of United Therapeutics worth $302K as of Q2 2026.
DG Capital Management left its United Therapeutics share count unchanged in Q2 2026.
United Therapeutics made up 0.06% of DG Capital Management's portfolio in Q2 2026, its #26 holding.
DG Capital Management first reported a position in United Therapeutics in Q4 2020 and has held it in 13 quarters since.
DG Capital Management's United Therapeutics position peaked at $29.7M in Q4 2021.
881 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on DG Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.